Competing in the Japanese Clinical Chemistry and Immunodiagnostics Markets

This new 559-page report from Venture Planning Group contains 103 tables, and presents a comprehensive analysis of the Japanese clinical chemistry and immunodiagnostics markets, including:

• Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.


• Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Japanese hospitals and commercial laboratories, including controls, calibrators and consumables.


• Five-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.


• Five-year reagent and instrument sales forecasts.


• Review of current instrumentation technologies, and a feature comparison of 50 high-, medium-, and low-volume/POC analyzers.


• Sales and market shares of leading reagent and instrument suppliers.


• Review of current and emerging technologies and their potential market applications.


• Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables.


• Profiles of 25 current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.


• Market penetration strategies, entry barriers and risks.

Contains 559 pages and 103 tables